HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoCalendarPricing
Theme 		Help

New: Instantly spot drawdowns, dips, insider moves, and breakout themes across Maps and Screener.

Learn More
Market News Market Pulse Stocks News ETF News Crypto News

Catalyst Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Catalyst Pharmaceuticals, Inc.

Jan-08
Catalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies CPRX GlobeNewswire
Jan-05
The University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS) CPRX GlobeNewswire
Dec-15
Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference CPRX GlobeNewswire
Nov-24
Catalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference CPRX GlobeNewswire
Nov-19
Catalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500 CPRX GlobeNewswire
Nov-18
Catalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference CPRX GlobeNewswire
Nov-05
Catalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update CPRX GlobeNewswire
Nov-04
Catalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work CPRX GlobeNewswire
Nov-03
Catalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference CPRX GlobeNewswire
Oct-22
Catalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025 CPRX GlobeNewswire
Oct-09
Catalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences CPRX GlobeNewswire
Oct-01
Catalyst Pharmaceuticals Announces $200 Million Share Repurchase Program CPRX GlobeNewswire
Aug-28
Catalyst Pharmaceuticals to Participate in Upcoming Investor Conferences CPRX GlobeNewswire
Aug-26
UPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals CPRX GlobeNewswire
Aug-25
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE (amifampridine) Patent Litigation with Lupin Pharmaceuticals CPRX GlobeNewswire
Aug-06
Catalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update CPRX GlobeNewswire
Aug-06
Lambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC) CPRX GlobeNewswire
Aug-04
Catalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors CPRX GlobeNewswire
Jul-22
Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 CPRX GlobeNewswire
Jun-02
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer CPRX GlobeNewswire
May-07
Catalyst Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Provides Business Update CPRX GlobeNewswire
Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved.